JNK_NN
-LRB-_-LRB-
c-Jun_NN
NH2-terminal_JJ
kinase_NN
-RRB-_-RRB-
is_VBZ
a_DT
target_NN
for_IN
antioxidants_NNS
in_IN
T_NN
lymphocytes_NNS
._.

AP-1_NN
has_VBZ
been_VBN
shown_VBN
to_TO
behave_VB
as_IN
a_DT
redox-sensitive_JJ
transcription_NN
factor_NN
that_WDT
can_MD
be_VB
activated_VBN
by_IN
both_CC
oxidant_JJ
and_CC
antioxidant_JJ
stimuli_NNS
._.

However_RB
,_,
the_DT
mechanisms_NNS
involved_VBN
in_IN
the_DT
activation_NN
of_IN
AP-1_NN
by_IN
antioxidants_NNS
are_VBP
largely_RB
unknown_JJ
._.

In_IN
this_DT
study_NN
we_PRP
show_VBP
that_IN
the_DT
structurally_RB
unrelated_JJ
antioxidant_JJ
agents_NNS
pyrrolidine_NN
dithiocarbamate_NN
-LRB-_-LRB-
PDTC_NN
-RRB-_-RRB-
,_,
butylated_VBN
hydroxyanisole_NN
,_,
and_CC
Nacetylcysteine_NN
activated_VBD
JNK_NN
-LRB-_-LRB-
c-Jun_NN
NH2-terminal_JJ
kinase_NN
-RRB-_-RRB-
in_IN
Jurkat_NN
T_NN
cells_NNS
._.

This_DT
activation_NN
differed_VBD
substantially_RB
from_IN
that_DT
mediated_VBN
by_IN
phorbol_NN
12-myristate_NN
13-acetate_NN
-LRB-_-LRB-
PMA_NN
-RRB-_-RRB-
and_CC
Ca2_NN
+_CC
ionophore_NN
or_CC
produced_VBN
by_IN
costimulation_NN
with_IN
antibodies_NNS
against_IN
the_DT
T_NN
cell_NN
receptor-CD3_JJ
complex_NN
and_CC
to_TO
CD28_NN
._.

The_DT
activation_NN
of_IN
JNK_NN
by_IN
classical_JJ
T_NN
cell_NN
stimuli_NNS
was_VBD
transient_JJ
,_,
whereas_IN
that_DT
mediated_VBN
by_IN
PDTC_NN
and_CC
butylated_VBN
hydroxyanisole_NN
-LRB-_-LRB-
but_CC
not_RB
N-acetylcysteine_NN
-RRB-_-RRB-
was_VBD
sustained_JJ
._.

The_DT
kinetics_NNS
of_IN
JNK_NN
activation_NN
correlated_VBD
with_IN
the_DT
expression_NN
of_IN
c-jun_NN
which_WDT
was_VBD
transient_JJ
after_IN
stimulation_NN
with_IN
PMA_NN
plus_CC
ionophore_NN
and_CC
prolonged_VBD
in_IN
response_NN
to_TO
PDTC_NN
,_,
which_WDT
also_RB
transiently_RB
induced_VBD
c-fos_NN
._.

In_IN
addition_NN
,_,
JNK_NN
activation_NN
by_IN
PMA_NN
plus_CC
ionophore_NN
was_VBD
sensitive_JJ
to_TO
inhibitors_NNS
of_IN
signaling_NN
pathways_NNS
involving_VBG
Ca2_NNP
+_NNP
,_,
protein_NN
kinase_NN
C_NN
,_,
and_CC
tyrosine_NN
phosphorylation_NN
,_,
which_WDT
failed_VBD
to_TO
inhibit_VB
the_DT
activation_NN
mediated_VBN
by_IN
PDTC_NN
._.

Transfection_NN
of_IN
trans-dominant_JJ
negative_JJ
expression_NN
vectors_NNS
of_IN
ras_NN
and_CC
raf_NN
,_,
together_RB
with_IN
AP-1-dependent_JJ
reporter_NN
constructs_NNS
,_,
as_RB
well_RB
as_IN
Western_NN
blot_NN
analysis_NN
using_VBG
anti-ERK_JJ
-LRB-_-LRB-
extracellular_JJ
signal-regulated_JJ
kinase_NN
-RRB-_-RRB-
antibodies_NNS
,_,
indicated_VBD
that_IN
the_DT
Ras\/Raf\/ERK_NN
pathway_NN
did_VBD
not_RB
appear_VB
to_TO
mediate_VB
the_DT
effect_NN
of_IN
the_DT
antioxidant_NN
._.

However_RB
,_,
the_DT
combined_JJ
treatment_NN
with_IN
PDTC_NN
and_CC
PMA_NN
,_,
two_CD
agents_NNS
that_WDT
synergize_VBP
on_IN
AP-1_NN
activation_NN
,_,
resulted_VBD
in_IN
the_DT
persistent_JJ
phosphorylation_NN
of_IN
ERK-2_NN
._.

In_IN
conclusion_NN
,_,
our_PRP$
results_NNS
identify_VBP
JNK_NN
as_IN
a_DT
target_NN
of_IN
antioxidant_JJ
agents_NNS
which_WDT
can_MD
be_VB
regulated_VBN
differentially_RB
under_IN
oxidant_JJ
and_CC
antioxidant_JJ
conditions_NNS
._.

